News

Press releases and news from regional sources, click on original post link to read the full article and see what’s trending. Click Here to Publish/Feature Your Company or Product News with Biotech Networks

News

Halozyme Announces Global Collaboration and License Agreement with Incyte to Support the Development of Subcutaneous Formulations of INCA033989 Using its ENHANZE® Technology

July 20, 2026 SDBN Comments Off on Halozyme Announces Global Collaboration and License Agreement with Incyte to Support the Development of Subcutaneous Formulations of INCA033989 Using its ENHANZE® Technology

Agreement provides Incyte the rights to develop and commercialize ENHANZE® with its mutCALR development program and an option to nominate up to two additional targets SAN DIEGO, July 20, 2026 /PRNewswire/ — Halozyme Therapeutics, Inc. […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Artiva Biotherapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 17, 2026 SDBN Comments Off on Artiva Biotherapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, July 17, 2026 (GLOBE NEWSWIRE) — Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with debilitating autoimmune diseases, today […]

No Picture
News

Mirador Therapeutics Expands Precision Immunology Portfolio with Exclusive License to KP-301, a Long-Acting Anti-C5a Antibody

July 16, 2026 SDBN Comments Off on Mirador Therapeutics Expands Precision Immunology Portfolio with Exclusive License to KP-301, a Long-Acting Anti-C5a Antibody

SAN DIEGO–(BUSINESS WIRE)–Mirador Therapeutics announced it has entered into an exclusive worldwide license agreement with Kira Pharmaceuticals for KP-301. Click here to view original post Click Here to Publish/Feature Your Company or Product News with […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Should We Be Worried About Cyclosporiasis?

July 16, 2026 SDBN Comments Off on Should We Be Worried About Cyclosporiasis?

Few people had heard of cyclosporiasis a week ago. Now it’s making headlines. As cases are reported in California, a parasitologist in the Skaggs School of Pharmacy and Pharmaceutical Sciences explains what people should know, […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Inhibrx Announces Amended Loan Agreement with Oxford Finance, Expanding Total Facility to $500.0 Million

July 16, 2026 SDBN Comments Off on Inhibrx Announces Amended Loan Agreement with Oxford Finance, Expanding Total Facility to $500.0 Million

SAN DIEGO, July 16, 2026 /PRNewswire/ — Inhibrx Biosciences, Inc. (“Inhibrx” or the “Company”) (Nasdaq: INBX), a clinical-stage biopharmaceutical company focused on developing novel biologic therapeutic candidates, today announced it entered into the Second Amendment […]

No Picture
News

Crown Bioscience Joins C-Path's NAMs Developer Coalition to Advance Human-Relevant Models in Drug Development

July 16, 2026 SDBN Comments Off on Crown Bioscience Joins C-Path's NAMs Developer Coalition to Advance Human-Relevant Models in Drug Development

SAN DIEGO–(BUSINESS WIRE)–Crown Bioscience is a global contract research organization (CRO) specializing in oncology drug discovery and development, today announced it has joined Critical Path Institute’s (C-Path) New Approach Methodologies Developer Coalition (NAMs-DC), a collaborative […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

GemPharmatech and Humlab Global Sign Strategic Agreement to Deliver Humanized Mouse Models for Improved Clinical Translation

July 15, 2026 SDBN Comments Off on GemPharmatech and Humlab Global Sign Strategic Agreement to Deliver Humanized Mouse Models for Improved Clinical Translation

SINGAPORE & SAN DIEGO–(BUSINESS WIRE)–GemPharmatech, an international provider of in vivo efficacy testing and genetically engineered animal models, and Humlab Global, a Singapore-based developer of humanized mouse models and translational research solutions, today announced the […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

MediciNova Announces Patient Enrollment Milestone Achieved in SEANOBI Study Expanded-Access-Program Evaluating MN?166 (ibudilast) in ALS patients

July 15, 2026 SDBN Comments Off on MediciNova Announces Patient Enrollment Milestone Achieved in SEANOBI Study Expanded-Access-Program Evaluating MN?166 (ibudilast) in ALS patients

LA JOLLA, Calif., July 15, 2026 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today […]

No Picture
News

Eyes On Eyecare launches Cited, a new way for retina specialists to engage with the latest journal articles

July 14, 2026 SDBN Comments Off on Eyes On Eyecare launches Cited, a new way for retina specialists to engage with the latest journal articles

Cited is PubMed meets Instagram Stories—a scrollable feed of peer-reviewed articles featuring rapid, 60-second expert reactions from the movers and shakers in retina. SAN DIEGO, July 14, 2026 /PRNewswire-PRWeb/ — Eyes On Eyecare today announced […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Axiom Biosciences Reports Positive Phase 1 Results for Investigational Stem Cell Therapy in Newborns with Severe Brain Injury

July 14, 2026 SDBN Comments Off on Axiom Biosciences Reports Positive Phase 1 Results for Investigational Stem Cell Therapy in Newborns with Severe Brain Injury

SAN DIEGO, July 14, 2026 (GLOBE NEWSWIRE) — Axiom Biosciences, a clinical-stage biotechnology company developing next-generation regenerative therapies and targeted biologics, today announced positive Phase 1 results for its investigational Wharton’s Jelly-derived mesenchymal stem cell […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Former Client and Three-Decade Data Sciences Leader John Reynders, PhD, Joins Rancho BioSciences Leadership on Board of Directors

July 14, 2026 SDBN Comments Off on Former Client and Three-Decade Data Sciences Leader John Reynders, PhD, Joins Rancho BioSciences Leadership on Board of Directors

This appointment reflects the company’s continued growth through investment in leadership that pairs deep scientific credibility with real-world R&D experience SAN DIEGO, July 14, 2026 /PRNewswire/ — Rancho BioSciences today announced the appointment of John […]

News

Atrium Therapeutics Announces FDA Clearance of Investigational New Drug Application for ATR 1072 for Treatment of PRKAG2 Syndrome

July 14, 2026 SDBN Comments Off on Atrium Therapeutics Announces FDA Clearance of Investigational New Drug Application for ATR 1072 for Treatment of PRKAG2 Syndrome

— ATR 1072 is the company’s first precision cardiology program to enter the clinic — — Corventis™ will be the first clinical trial for people living with PRKAG2 syndrome that evaluates a potential treatment for […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
News

Converging at BIO, ACROBiosystems Connects Emerging Innovation Assets with Global Strategic Opportunities

July 13, 2026 SDBN Comments Off on Converging at BIO, ACROBiosystems Connects Emerging Innovation Assets with Global Strategic Opportunities

SAN DIEGO, July 13, 2026 /PRNewswire/ — Ahead of the BIO International Convention, BIOSeedin Summer Innovation Partnering Summit was successfully held at Wyndham San Diego Bayside, California. Hosted by bioSeedin, the summit’s discussion topics were […]